BIOMARIN PHARMACEUTICAL INC — Director's Dealing 2012

May 10, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2012-04-30

Reporting Person: ASELAGE STEVE (EVP, Chief Business Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2012-04-30	CommonStock	A	1006	$19.346	Acquired	47685	Direct
2012-05-08	Common Stock	A	16000	—	Acquired	63685	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2012-05-08	Stock Option (right to buy)	$37.46	A	40000	Acquired	2022-05-07	Common Stock (40000)	Direct

Footnotes

F1: The reporting person is voluntarily reporting the acquisition of shares of the issuer's common stock pursuant to the issuer's Employee Stock Purchase Plan ("ESPP"), for the ESPP purchase period of November 1, 2011 to April 30, 2012.

F2: Restricted stock units granted on May 8, 2012. Price not applicable.

F3: Options vest 6/48ths on November 8, 2012 and 1/48th on the 8th of each month thereafter.